PEELAERTS, W.; BERGKVIST, L.; GEORGE, S.; JOHNSON, M.; MEYERDIRK, L.; SCHULZ, E.; STEINER, J. A.; MADAJ, Z.; MA, J.; BECKER, K.; NILSSON, K. P. R.; COLCA, J. R.; BRUNDIN, P. Inhibiting the mitochondrial pyruvate carrier does not ameliorate synucleinopathy in the absence of inflammation or metabolic deficits. Free Neuropathology, [S. l.], v. 1, p. 33, 2020. DOI: 10.17879/freeneuropathology-2020-3049. Disponível em: Acesso em: 3 mar. 2024.